News & Updates

EndeavorRx improves attention span in children ages 8-12 years old

Delivered through a video game experience, EndeavorRx is indicated to improve attention function as measured by computer-based testing in children ages 8-12 years old with primarily inattentive or combined-type ADHD, who have a demonstrated attention issue. EndeavorRx was reviewed through FDA’s de novo pathway and its clearance creates a new class of digital therapeutics. EndeavorRx is designed to directly target and activate neural systems through the presentation of sensory stimuli and motor challenges to improve cognitive functioning. Eddie Martucci, chief executive officer…

News & Updates

Continuous glucose monitoring helps in managing diabetes

Technology often makes life easier to manage, and new research confirms that's definitely the case for people with type 1 diabetes. Continuous glucose monitors -- devices that approximate blood sugar levels every few minutes -- can help teens and young adults better manage their diabetes. They can also help older adults prevent dangerously low blood sugar levels (hypoglycemia), according to two new studies. "The advent of continuous glucose monitoring (CGM) technology has revolutionized outpatient diabetes care in the past decade,"…

News & Updates

MD-Logic Artificial Pancreas algorithm for controlling patient glucose levels

The development of the MD-Logic algorithm was initiated at the Institute of Endocrinology and Diabetes at the Schneider Children’s Medical Centre of Israel headed by Prof. Moshe Phillip in 2007. The project spawned the creation of DreaMed Diabetes and an agreement with Medtronic, leading to the implementation of the algorithm into the MiniMed 780G system. The “MD-Logic Artificial Pancreas algorithm,” is an advanced hybrid closed loop system for controlling patient glucose levels. It can alter both basal insulin and provide…

News & Updates

Medtronic wins EU CE Mark for its new device

Medtronic won the EU CE Mark for its MiniMed 780G closed loop insulin pump that features both Medtronic’s own SmartGuard algorithm and MD-Logic, an algorithm developed by DreaMed Diabetes, a small Israeli firm. The system, indicated to be used by patients with type 1 diabetes between ages 7 and 80, automatically delivers both basal insulin and correcting boluses every five minutes, if necessary. Such close monitoring and control of blood glucose levels may help patients stay within a healthy range…

News & Updates

Swittons unveils new device model featuring fingerprint technology

Swittons, a P360 company, recently announced that its complete lineup of customizable IoT powered devices now includes integration with Microsoft Teams. The integration enables voice, video and online collaboration at the push of a button. The company also revealed a new device model, which features fingerprint technology for enhanced security. Swittons breaks down communication barriers within the healthcare and life sciences industries by facilitating remote, on-demand communication for pharmaceutical commercial, clinical and patient services organizations, healthcare providers and physicians. By providing an alternative…